KolmarBNH
콜마비앤에이치 · 200130
Health Care Pharmaceuticals · KOSDAQ
Market cap US$219.1M (₩302.4B)
Overview
KolmarBNH develops and produces health supplements and cosmetics, everyday wellness products such as immune-support and digestive-health foods, as well as skincare, on an ODM/OEM basis, meaning it manufactures finished goods to other brands' specifications.
It supplies customers across South Korea and exports to more than two dozen countries, including China, the United States, and Japan. Listed on KOSDAQ, Korea's tech and small-cap board, the company earns the majority of its revenue from health supplements, with cosmetics making up most of the remainder.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$420M
- FY2024US$446.1M
- FY2025US$416.6M
Operating profit
- FY2023US$21.9M
- FY2024US$17.8M
- FY2025US$19.3M
Net income
- FY2023US$13.6M
- FY2024US$12.5M
- FY2025−US$16.4M
Key ratios (FY2025)
Why it matters
A subsidiary, 근오농림㈜, grows and supplies raw botanical ingredients, including Korean medicinal herbs, directly to the group, giving it an in-house upstream materials capability.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?